4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-20-000054
President and CEO sold 3,253 shares at $3.86 ($12,557)
- President and CEO acquired 10,938 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Brunn Carsten · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-06-01 | Exercise or conversion : show line 1 in the form | +10,938 | 89,415 | D | ||
| 2020-06-02 | Sale : show line 2 in the form | −3,253 | $3.86 | $12,557 | 86,162 | D |
| Open-market sales · 3,253 sh · avg $3.86 · $12,557 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2020-06-01 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −10,938 | 10,938 | 109,375 | D |
Loading xslF345X03/wf-form4_159121693539654.xml…